Banque Pictet & Cie Sa Exact Sciences Corp Transaction History

Banque Pictet & Cie Sa

$13.1 Billion
Q3 2024

A detailed history of Banque Pictet & Cie Sa transactions in Exact Sciences Corp stock. As of the latest transaction made, Banque Pictet & Cie Sa holds 189,233 shares of EXAS stock, worth $11 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

189,233

Previous 183,034 3.39%

Holding current value

$11 Million

Previous $7.73 Million 66.61%

% of portfolio

0.1%

Previous 0.07%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$42.43 - $70.83 $263,023 - $439,075	6,199 Added 3.39%	189,233 $12.9 Million
Q2 2024 Jul 25, 2024	BUY	$41.33 - $74.26 $2.88 Million - $5.17 Million	69,585 Added 61.34%	183,034 $7.73 Million
Q1 2024 May 06, 2024	SELL	$56.27 - $73.77 $4.35 Million - $5.7 Million	-77,250 Reduced 40.51%	113,449 $7.83 Million
Q4 2023 Feb 09, 2024	SELL	$59.06 - $75.72 $4.84 Million - $6.2 Million	-81,942 Reduced 30.05%	190,699 $14.1 Million
Q3 2023 Nov 02, 2023	SELL	$65.94 - $99.04 $1.48 Million - $2.22 Million	-22,372 Reduced 7.58%	272,641 $18.6 Million
Q2 2023 Aug 04, 2023	BUY	$62.68 - $95.05 $143,349 - $217,379	2,287 Added 0.78%	295,013 $27.7 Million
Q1 2023 May 01, 2023	SELL	$47.19 - $70.77 $2.08 Million - $3.12 Million	-44,020 Reduced 13.07%	292,726 $19.8 Million
Q4 2022 Feb 06, 2023	SELL	$30.35 - $53.15 $2.59 Million - $4.54 Million	-85,459 Reduced 20.24%	336,746 $0
Q3 2022 Nov 10, 2022	SELL	$31.97 - $49.37 $54,093 - $83,534	-1,692 Reduced 0.4%	422,205 $13.7 Billion
Q2 2022 Aug 08, 2022	SELL	$35.61 - $76.23 $2.35 Million - $5.03 Million	-66,042 Reduced 13.48%	423,897 $16.7 Million
Q1 2022 May 04, 2022	BUY	$57.56 - $82.54 $174,982 - $250,921	3,040 Added 0.62%	489,939 $34.3 Million
Q4 2021 Feb 02, 2022	BUY	$72.5 - $100.68 $7.56 Million - $10.5 Million	104,229 Added 27.24%	486,899 $37.9 Million
Q3 2021 Nov 10, 2021	SELL	$90.24 - $124.05 $1.15 Million - $1.58 Million	-12,714 Reduced 3.22%	382,670 $36.5 Million
Q2 2021 Aug 12, 2021	BUY	$93.66 - $139.27 $8.57 Million - $12.7 Million	91,495 Added 30.11%	395,384 $49.2 Million
Q1 2021 May 11, 2021	BUY	$116.57 - $155.01 $9.37 Million - $12.5 Million	80,420 Added 35.99%	303,889 $40 Million
Q4 2020 Feb 10, 2021	SELL	$99.61 - $142.12 $1.62 Million - $2.31 Million	-16,223 Reduced 6.77%	223,469 $29.6 Million
Q3 2020 Nov 10, 2020	BUY	$72.92 - $102.01 $1.44 Million - $2.01 Million	19,734 Added 8.97%	239,692 $24.4 Million
Q2 2020 Aug 13, 2020	BUY	$55.75 - $92.75 $50,119 - $83,382	899 Added 0.41%	219,958 $19.1 Million
Q1 2020 Apr 30, 2020	BUY	$37.9 - $104.44 $5.79 Million - $15.9 Million	152,714 Added 230.18%	219,059 $12.7 Million
Q4 2019 Feb 03, 2020	BUY	$77.66 - $99.74 $5.15 Million - $6.62 Million	66,345 New	66,345 $6.14 Million

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.3B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Pictet & Cie Sa with notifications on news.

Account

Banque Pictet & Cie Sa Exact Sciences Corp Transaction History